In December 2019, a cluster of patients with pneumonia of unknown cause appeared in Wuhan, Hubei. Governments at all levels and Department of Health Administration highly valued and rapidly organized the centers for Disease Control and Prevention (CDC), medical institutions, and scientific research academies to conduct a survey, rescue, and collaborative research. This new antigen was quickly identified as a novel coronavirus, named as 2019-nCoV by World Health Organization (WHO). Meanwhile, the pneumonia caused by it was named as novel coronavirus pneumonia. Implementing the decisions by the CPC Central Committee and State Council with Xi at the core, the whole country took comprehensive actions in social mobilization and deployment, taking epidemic control a most important work in the immediate future. The spread of the epidemic has been effectively controlled. However, novel coronavirus has spread to the whole world thereafter, so it called for closer international cooperation in epidemic prevention and control. Based on this situation, it was urgent to set a new MOOC program about COVID-19 and impart scientific knowledge of the disease to foreign students, undergraduate students, and all the other common people abroad, laying a solid foundation for the triumph of the war against COVID-19. The novel coronavirus is a new strain of coronavirus that had never been found in humans before. This huge family already known can cause cold or Middle East Respiratory Syndrome (MERS), Severe Acute Respiratory Syndrome (SARS) and other severe diseases. The main signs and symptoms of the infected people include respiratory symptoms, fever, dry cough, shortness of breath, and dyspnea, etc. In severe and critical cases, there will appear pneumonia, severe acute respiratory syndrome, kidney failure, and even death. The two-month war against COVID-19 has helped us accumulate loads of experience in disease prevention, control, diagnosis, and treatment, which can be shared with the whole world as a reference. In front of the need of our students and common people on COVID-19 prevention knowledge, the Health Science Center of Xi’an Jiaotong University has organized related experts to issue the English lectures of the epidemic prevention and control for people at home and abroad and international community. The contents are mainly about “Introduction,Diagnose,therapeutic Strategy and Prevention for COVID-19”. Through this course, we sincerely hope all our students and the common peoples of the world have scientific knowledge of COVID-19 and increased self-protection awareness, improving international community’s capacity for the prevention and control of COVID-19. We should work in great unity, take science-based and targeted measures against the epidemic, and have confidence in conquering the virus.

Learn how advances in biomedicine hold the potential to revolutionize drug development, drug treatments, and disease prevention: where are we now, and what does the future hold? This course will present short primers in genetics and mechanisms underlying variability in drug responses. A series of case studies will be used to illustrate principles of how genetics are being brought to bear on refining diagnoses and on personalizing treatment in rare and common diseases. The ethical and operational issues around how to implement large scale genomic sequencing in clinical practice will be addressed. After completing this course, learners will understand 1. The ways in which genetic variants can contribute to human disease susceptibility 2. How to choose among drug therapies based on genetic factors 3. That the functional consequences of the vast majority of genetic variants discovered by modern sequencing are unknown. This course is targeted primarily at physicians 5+ years out of training. Other healthcare providers, medical/health sciences students, and members of the public may also be interested. Course launches January 15, 2016. * The information presented in “Case Studies in Personalized Medicine” is offered for educational and informational purposes only, and should not be construed as personal medical advice. If you have questions or concerns about a medical matter, please consult your doctor or other professional healthcare provider.

The University of California San Diego, Skaggs School of Pharmacy and Pharmaceutical Sciences Drug Development course brings you lectures from both faculty and industry experts. With this course, recorded on campus at UCSD, we seek to share our access to top people in the field who bring an unprecedented range of expertise on drug development. In this course you will learn the different stages of clinical development as well as the regulatory including but not limited to, an Investigational New Drug Application (IND), New Drug Application (NDA), and product labeling. Additionally you will learn how to Incorporate study design methods for consideration in the design of clinical protocols to assess safety, tolerability, and efficacy in multiple therapeutic areas. In this course you will learn the different phases of clinical development: * Phase 1 or early stage clinical trial are conducted primar­ily to determine how the new drug works in humans, its safety profile and to predict its dosage range. It typically involves between 30 and 100 healthy volunteers. * Phase 2 or Proof of Concept POC studies test for efficacy as well as safety and side effects in a group of between 30 to 200 hundred patients with the disease for which the new drug is being developed. * Phase 3 or late stage clinical development involve much larger group of patients, between a few hundred to thousands, depending on the indication, which will help determine if the new drug can be considered both safe and effective. It will involve control groups using placebo and/or current treatment as a comparison. * Product registration and approval process after a drug is considered safe and effective from Phase 3 trials, it must be authorized in each individual country before it can be marketed. All data gen­erated about the small molecule or biologic is collected and submitted to the regulatory authorities in the US at the FDA, Food and Drug Administration FDA, in Europe the EMA or European Medicines Agency, Japan Ministry of Health and other countries which may require their own national approvals. This course is intended as part 2 of a series: Drug Discovery (https://www.coursera.org/learn/drug-discovery), Drug Development and Drug Commercialization (https://www.coursera.org/learn/drug-commercialization). We would highly recommend that you take the courses in order since it will give you a better understanding on how a drug is discovered in the lab before being tested in clinical trials and then launched in the market place.

This course was developed by the Karolinska Institutet (KI) and the Federation of the European Academies of Medicine (FEAM) as part of the research project 'Pan-European Response to the Impacts of the COVID-19 and future Pandemics and Epidemics' (PERISCOPE). Funded by the European Commission Research Funding programme Horizon 2020 under the Grant Agreement number 101016233, PERISCOPE investigates the broad socio-economic and behavioural impacts of the COVID-19 pandemic, to make Europe more resilient and prepared for future large-scale risks. This course is primarily aimed at highly specialised technical professional groups (healthcare authorities, policymakers, researchers and other academics) interested in learning more about the One Health approach. The modules are for participants who are likely to have previous knowledge about the concept in one specific area or pillar but not necessarily in all of them. The course will provide basic knowledge and contextualisation of One Health in creeping crises, such as the COVID-19 pandemic. Attending the course, participants will identify enablers, limitations, barriers, and next steps in and to the One Health concept and operationalisation. PERISCOPE website: https://www.periscopeproject.eu/ KI website: https://ki.se/en FEAM website: https://www.feam.eu/

Effective communication is a core skill that nearly every health professional will need and use during their careers. Yet, few health professionals receive even basic training in how to design communications to be clear and successful. As “foundational skills,” the content in this course can be applied to both oral and written communication, within and beyond health. Learners will develop the skills to: analyze and tailor a communication effort for different audiences, develop clear messages, create logical and compelling stories, understand and apply important considerations with language as well as nonverbal communication. This course is valuable and appropriate for both beginning and experienced health professionals who need to communicate effectively with other professionals, patients, policymakers, or the broader public.. Content is relevant to public health professionals, clinicians of all types (medical, nursing, dentists, social work, etc.), health advocates, and scientists and researchers in any health domain..

In this class, we present a broad overview of the field of medical software. You will learn from Yale professors and a series of industry experts who connect the course concepts to their real world applications. We begin by discussing medical device regulatory structures, data privacy and cybersecurity regulations, and key support technologies such quality management systems and risk management. We then take a detailed look at the medical software life cycle, starting with identifying user needs, mapping these to system requirements and then the process of software design, coding, testing and validation. We continue by exploring issues related to the use of machine learning techniques in medical applications from both a software engineering and a regulatory perspective. We conclude with a discussion of the business and management issues in this area focusing on the impact on digital health on modern healthcare and issues related to starting new ventures. This is a class aimed at either third- or fourth-year undergraduates in computer science, biomedical engineering, and related fields, and to junior software engineers currently either working in, or interested in moving to, the medical device industry.

Epidemiological research is ubiquitous. Even if you don’t realise it, you come across epidemiological studies and the impact of their findings every single day. You have probably heard that obesity is increasing in high income countries or that malaria is killing millions of people in low income countries. It is common knowledge that smoking causes cancer and that physical activity is protective against heart disease. These facts may seem obvious today, but it took decades of epidemiological research to produce the necessary evidence. In this course, you will learn the fundamental tools of epidemiology which are essential to conduct such studies, starting with the measures used to describe the frequency of a disease or health-related condition. You will also learn how to quantify the strength of an association and discuss the distinction between association and causation. In the second half of the course, you will use this knowledge to describe different strategies for prevention, identify strengths and weaknesses of diagnostic tests and consider when a screening programme is appropriate.

Please join us for an exciting and innovative journey, examining one of the most important and often overlooked aspects of the oncology setting: Traditional Herbal Medicine in Supportive Cancer Care. This course is presented with short lectures offering a wide range of issues related to the principles and practice of herbal medicine in cancer care. The course includes interviews with leading world experts from the field of Integrative Oncology, from the U.S. and Canada, as well as Europe, the Middle East, China and Japan. By the end of the course, you will: • Understand core concepts in Integrative Oncology, as they relate to the supportive/palliative cancer care setting • Acquire effective communication skills which will foster a better understanding of patients' views on herbal medicine, while providing guidance on the safe and effective use of these products • Be able to design, together with patients, caregivers and healthcare providers, a patient-tailored and cultural-sensitive integrative oncology treatment program, including the use of herbal medicine • Be acquainted with leading "players" who can share their experience in creating and implementing an integrative oncology program The course has been specially designed to provide information and guidance at a level appropriate for patients and non-medical participants, as well as medical professionals interested in receiving evidence-based guidance on the safety and effectiveness of herbal medicine in cancer care.

Cannabis is a group of flowering plants that has been long used for industrial, recreational and medical purposes. When relating to its medical use, the terms "Medical Cannabis" or "Medical marijuana" has become prevalent. In this course we will use the term "Medical Cannabis". Nowadays, Medical Cannabis involves multiple medical disciplines such as neuroscience, pain, pharmacology, oncology, psychiatry and more. Moreover, it has cultural, agricultural and social, legal and political implications. This course will give you a solid ground to understand the whole picture. By completing this course, you will gain a broad understanding and knowledge base related to medical use of cannabis for pain control. You will be exposed to a wide range of topics such as historical use of cannabis in ancient times, botanic aspects of the plants, and potential benefits and risks associated with its medical use to both individuals and society.

People are the most valuable asset of any business, but they are also the most unpredictable, and the most difficult asset to manage. And although managing people well is critical to the health of any organization, most managers don't get the training they need to make good management decisions. Now, award-winning authors and renowned management Professors Mike Useem and Peter Cappelli of the Wharton School have designed this course to introduce you to the key elements of managing people. Based on their popular course at Wharton, this course will teach you how to motivate individual performance and design reward systems, how to design jobs and organize work for high performance, how to make good and timely management decisions, and how to design and change your organization’s architecture. By the end of this course, you'll have developed the skills you need to start motivating, organizing, and rewarding people in your organization so that you can thrive as a business and as a social organization.